Ozanian named chief experience officer at JUICE Pharma
Industry veteran Chris Ozanian has been appointed chief experience officer at creative and marketing communications agency JUICE Pharma Worldwide.
Pharmacy
ProBioGen collaborates with Boehringer Ingelheim
ProBioGen announced on Tuesday a new non-exclusive collaboration with Boehringer Ingelheim on ProBioGen’s DirectedLuck transposase technology.
FDA grants accelerated approval for Alzheimer’s Disease Treatment
The U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the accelerated approval pathway for the treatment of Alzheimer’s disease. Leqembi is the second of a new category of medications approved for Alzheimer’s disease that target the fundamental pathophysiology of the disease.
Branded Drug Report 2023: Lisa Joldersma, PhRMA
In recent decades, pharmacy benefit managers have grown into shadowy and hugely influential players in the prescription drug supply chain. For the most part, they have managed to avoid public scrutiny and government regulation.
Aurobindo receives FDA approval for lacosamide tablets
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application lacosamide tablets USP, 50mg, 100mg, 150mg, and 200mg.
Aurobindo gets FDA approval for dimethyl fumarate delayed-release capsules
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Dimethyl Fumarate Delayed-Release Capsules, 120mg and 240mg.
Branded Drug Report 2023: John O’Brien, NPC
A contentious midterm election is behind us, and while pundits and other experts argue about what the results mean, those of us who deeply care about sound health care policy can hope for a new year where solid evidence and the quest for transparent information matters at least as much as political
Branded Drug Report 2023: USP ensures drug quality from lab to pharmacy shelf
pharmaceutical and commercial — has become even more evident amid the COVID-19 pandemic. These are among the many reasons why today is both an exciting and challenging time to practice
PQA expands the Social Determinants of Health Resource Guide
ALEXANDRIA, Va. – The Pharmacy Quality Alliance (PQA) has expanded the PQA Social Determinants of Health (SDOH) Resource Guide. The second edition of this guide profiles 32 SDOH services, including 12 new services and updates to nine initiatives from the first edition.
Alex Gourlay appointed as executive chair of Holland & Barrett
Former Walgreens executive Alex Gourlay has been appointed executive chair of Holland & Barrett, a leading wellness business and one of the largest in Europe.
Hy-Vee offering more options for Medicare Part D beneficiaries
Hy-Vee, Inc. announced that Medicare Part D beneficiaries are now able to access reduced-cost monthly insulin supplies and free Shingrix vaccines at all Hy-Vee Pharmacy locations, as outlined in the recent Inflation Reduction Act, which went into effect Jan. 1, 2023.
NIH rolling out Home Test to Treat program
The National Institutes of Health, in collaboration with the Administration for Strategic Preparedness and Response (ASPR) at the U.S.
PQA appoints 2023 board, executive committee
ALEXANDRIA, Va. – The Pharmacy Quality Alliance (PQA) Board of Directors approved its 2023 Executive Committee and appointed six new members to the 25-member board during its 2022 fourth quarter meeting. The appointments are effective January 1.
NCPA releases third episode of “Show Me” reality series
ALEXANDRIA, Va. – The National Community Pharmacists Association today released the third episode of its educational reality series, “Show Me.
Camber Pharmaceuticals launches generic Kuvan
PISCATAWAY, N.J.– Camber Pharmaceuticals announced the addition of sapropterin dihydrochloride tablets and powder for oral solution to its current portfolio.
CVS, Walgreens will be able to sell abortion pills
With family planning rights under major threat in several states, the Food and Drug Administration (FDA) announced this week a move to expand access to abortion. Now chains such as CVS and Walgreens will be able to sell abortion pills to those with prescriptions.